Variable | Quartile 1N=876 | Quartile 2 N=876 | Quartile 3N=876 | Quartile 4N=876 | P |
---|---|---|---|---|---|
Body weight – kg | 97 (±19) | 83 (±15) | 75 (±14) | 65 (±13) | <0.001 |
NTproBNP – ng/L | 724 (292-1486) | 817 (322-1859) | 1116 (434-2717) | 2043 (805-4812) | <0.001 |
NYHA class III or IV – % | 27% | 24% | 31% | 34% | <0.001 |
Lung crackles O/E - % | 14% | 12% | 18% | 22% | <0.001 |
Peripheral oedema O/E - % | 41% | 38% | 39% | 43% | 0.18 |
Raised JVP O/E - % | 13% | 14% | 16% | 20% | <0.001 |
1 year mortality† - % | 7% | 8% | 10% | 18% | <0.001 |
Legend† - amongst those with at least 1 year follow up (N=3330; 95% of total population)Abbreviations used: H-PVS - Plasma volume status calculated using the Hakim formula; NTproBNP - N-terminal pro-B-type natriuretic peptide; NYHA - New York Heart Association; O/E - on examination.